Complete remission in a patient with treatment refractory bullous pemphigoid after a single dose of omalizumab

• Main Authors: Surabhi Sinha (Author), Diksha Agrawal (Author), Kabir Sardana (Author), Anita Kulhari (Author), Purnima Malhotra (Author)
• Format: Book
• Published: Wolters Kluwer Medknow Publications, 2020-01-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Bullous pemphigoid (BP) is an autoimmune disorder known to be mediated by immunoglobulin G (IgG) autoantibodies. The role of immunoglobulin E (IgE) antibodies is being investigated as their presence has been described in severe cases. Herein, we report a patient of BP who was refractory to most conv...